<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p138" style="overflow: hidden; position: relative; background-color: white; width: 908px; height: 1286px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_138{left:130px;bottom:1195px;letter-spacing:0.22px;}
#t2_138{left:796px;bottom:1195px;letter-spacing:0.13px;}
#t3_138{left:130px;bottom:1115px;letter-spacing:-0.01px;}
#t4_138{left:259.8px;bottom:1115.2px;letter-spacing:-0.21px;}
#t5_138{left:183.3px;bottom:1099px;letter-spacing:-0.21px;}
#t6_138{left:272px;bottom:1099px;letter-spacing:-0.01px;}
#t7_138{left:130px;bottom:1083px;letter-spacing:-0.01px;}
#t8_138{left:250.1px;bottom:1082.8px;letter-spacing:-0.21px;}
#t9_138{left:183.3px;bottom:1066.6px;letter-spacing:-0.21px;}
#ta_138{left:183.3px;bottom:1050.3px;letter-spacing:-0.2px;}
#tb_138{left:405px;bottom:1050px;letter-spacing:-0.01px;}
#tc_138{left:130px;bottom:1034px;letter-spacing:-0.01px;}
#td_138{left:253.2px;bottom:1034.1px;letter-spacing:-0.2px;}
#te_138{left:183.3px;bottom:1017.9px;letter-spacing:-0.21px;}
#tf_138{left:432px;bottom:1018px;letter-spacing:-0.01px;}
#tg_138{left:130px;bottom:985px;letter-spacing:-0.01px;}
#th_138{left:381.7px;bottom:985.4px;letter-spacing:-0.21px;}
#ti_138{left:183.3px;bottom:969.2px;letter-spacing:-0.2px;}
#tj_138{left:301px;bottom:969px;letter-spacing:-0.01px;}
#tk_138{left:130px;bottom:953px;letter-spacing:-0.01px;}
#tl_138{left:255.3px;bottom:953px;letter-spacing:-0.21px;}
#tm_138{left:183.3px;bottom:936.7px;letter-spacing:-0.21px;}
#tn_138{left:229px;bottom:937px;letter-spacing:-0.01px;}
#to_138{left:130px;bottom:921px;letter-spacing:-0.01px;}
#tp_138{left:293.2px;bottom:920.5px;letter-spacing:-0.2px;}
#tq_138{left:183.3px;bottom:904.3px;letter-spacing:-0.21px;}
#tr_138{left:183.3px;bottom:888.1px;letter-spacing:-0.2px;}
#ts_138{left:598px;bottom:888px;letter-spacing:-0.01px;}
#tt_138{left:185px;bottom:872px;letter-spacing:-0.01px;}
#tu_138{left:130px;bottom:856px;letter-spacing:-0.01px;}
#tv_138{left:264.2px;bottom:855.6px;letter-spacing:-0.21px;}
#tw_138{left:183.3px;bottom:839.4px;letter-spacing:-0.21px;}
#tx_138{left:669px;bottom:839px;letter-spacing:-0.01px;}
#ty_138{left:185px;bottom:823px;letter-spacing:-0.01px;}
#tz_138{left:130px;bottom:807px;letter-spacing:-0.01px;}
#t10_138{left:284.9px;bottom:806.9px;letter-spacing:-0.21px;}
#t11_138{left:183.3px;bottom:790.7px;letter-spacing:-0.21px;}
#t12_138{left:183.3px;bottom:774.6px;letter-spacing:-0.22px;}
#t13_138{left:408px;bottom:775px;letter-spacing:-0.01px;}
#t14_138{left:130px;bottom:742px;letter-spacing:-0.01px;}
#t15_138{left:277.4px;bottom:742.1px;letter-spacing:-0.21px;}
#t16_138{left:183.3px;bottom:725.9px;letter-spacing:-0.22px;}
#t17_138{left:429px;bottom:726px;letter-spacing:-0.01px;}
#t18_138{left:130px;bottom:693px;letter-spacing:-0.01px;}
#t19_138{left:246.8px;bottom:693.5px;letter-spacing:-0.21px;}
#t1a_138{left:183.3px;bottom:677.2px;letter-spacing:-0.21px;}
#t1b_138{left:597px;bottom:677px;letter-spacing:-0.01px;}
#t1c_138{left:130px;bottom:645px;letter-spacing:-0.01px;}
#t1d_138{left:276.1px;bottom:644.8px;letter-spacing:-0.21px;}
#t1e_138{left:183.3px;bottom:628.5px;letter-spacing:-0.23px;}
#t1f_138{left:252px;bottom:629px;letter-spacing:-0.01px;}
#t1g_138{left:130px;bottom:612px;letter-spacing:-0.01px;}
#t1h_138{left:284.1px;bottom:612.3px;letter-spacing:-0.21px;}
#t1i_138{left:183.3px;bottom:596.1px;letter-spacing:-0.21px;}
#t1j_138{left:183.3px;bottom:579.9px;letter-spacing:-0.21px;}
#t1k_138{left:266px;bottom:580px;letter-spacing:-0.01px;}
#t1l_138{left:130px;bottom:564px;letter-spacing:-0.01px;}
#t1m_138{left:269.4px;bottom:563.6px;letter-spacing:-0.21px;}
#t1n_138{left:183.3px;bottom:547.4px;letter-spacing:-0.21px;}
#t1o_138{left:278px;bottom:547px;letter-spacing:-0.01px;}
#t1p_138{left:130px;bottom:531px;letter-spacing:-0.01px;}
#t1q_138{left:269.4px;bottom:531.2px;letter-spacing:-0.21px;}
#t1r_138{left:183.3px;bottom:515px;letter-spacing:-0.23px;}
#t1s_138{left:689px;bottom:515px;letter-spacing:-0.01px;}
#t1t_138{left:185px;bottom:499px;letter-spacing:-0.01px;}
#t1u_138{left:130px;bottom:483px;letter-spacing:-0.01px;}
#t1v_138{left:278.6px;bottom:482.5px;letter-spacing:-0.21px;}
#t1w_138{left:183.3px;bottom:466.3px;letter-spacing:-0.23px;}
#t1x_138{left:704px;bottom:466px;letter-spacing:-0.01px;}
#t1y_138{left:185px;bottom:450px;letter-spacing:-0.01px;}
#t1z_138{left:130px;bottom:434px;letter-spacing:-0.01px;}
#t20_138{left:362.9px;bottom:433.8px;letter-spacing:-0.2px;}
#t21_138{left:183.3px;bottom:417.7px;letter-spacing:-0.21px;}
#t22_138{left:548px;bottom:418px;letter-spacing:-0.01px;}
#t23_138{left:185px;bottom:401px;letter-spacing:-0.01px;}
#t24_138{left:130px;bottom:385px;letter-spacing:-0.01px;}
#t25_138{left:267.6px;bottom:385.2px;letter-spacing:-0.21px;}
#t26_138{left:183.3px;bottom:368.9px;letter-spacing:-0.21px;}
#t27_138{left:183.3px;bottom:352.7px;letter-spacing:-0.23px;}
#t28_138{left:304px;bottom:353px;letter-spacing:-0.01px;}
#t29_138{left:130px;bottom:337px;letter-spacing:-0.01px;}
#t2a_138{left:267.6px;bottom:336.6px;letter-spacing:-0.22px;}
#t2b_138{left:183.3px;bottom:320.3px;letter-spacing:-0.21px;}
#t2c_138{left:569px;bottom:320px;letter-spacing:-0.01px;}
#t2d_138{left:130px;bottom:288px;letter-spacing:-0.01px;}
#t2e_138{left:256.6px;bottom:287.9px;letter-spacing:-0.22px;}
#t2f_138{left:183.3px;bottom:271.6px;letter-spacing:-0.21px;}
#t2g_138{left:431px;bottom:272px;letter-spacing:-0.01px;}
#t2h_138{left:130px;bottom:255px;letter-spacing:-0.01px;}
#t2i_138{left:521.2px;bottom:255.4px;letter-spacing:-0.2px;}
#t2j_138{left:183.3px;bottom:239.2px;letter-spacing:-0.22px;}
#t2k_138{left:649px;bottom:239px;letter-spacing:-0.01px;}
#t2l_138{left:185px;bottom:223px;letter-spacing:-0.01px;}
#t2m_138{left:130px;bottom:207px;letter-spacing:-0.01px;}
#t2n_138{left:521.2px;bottom:206.7px;letter-spacing:-0.2px;}
#t2o_138{left:183.3px;bottom:190.5px;letter-spacing:-0.22px;}
#t2p_138{left:645px;bottom:191px;letter-spacing:-0.01px;}
#t2q_138{left:185px;bottom:174px;letter-spacing:-0.01px;}
#t2r_138{left:130px;bottom:158px;letter-spacing:-0.01px;}
#t2s_138{left:274.7px;bottom:158.1px;letter-spacing:-0.21px;}
#t2t_138{left:183.3px;bottom:141.7px;letter-spacing:-0.2px;}
#t2u_138{left:560px;bottom:142px;letter-spacing:-0.01px;}
#t2v_138{left:185px;bottom:126px;letter-spacing:-0.01px;}
#t2w_138{left:202px;bottom:69px;letter-spacing:0.23px;}

.s0_138{font-size:11px;font-family:NotoSans-Regular_7j-;color:#000;}
.s1_138{font-size:12px;font-family:NotoSans-Regular_7j-;color:#000;}
.s2_138{font-size:13px;font-family:NotoSans-Regular_7j-;color:#000;}
.s3_138{font-size:14px;font-family:NotoSans-Regular_7j-;color:#000;}
.t.m0_138{transform:matrix(0.957,0,-0.29,0.96,0,0);}
</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts138" type="text/css" >

@font-face {
	font-family: NotoSans-Regular_7j-;
	src: url("fonts/NotoSans-Regular_7j-.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg138Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg138" style="-webkit-user-select: none;"><object width="908" height="1286" data="138/138.svg" type="image/svg+xml" id="pdf138" style="width:908px; height:1286px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div class="text-container"><span id="t1_138" class="t s0_138">13. Bibliography </span><span id="t2_138" class="t s1_138">138 </span>
<span id="t3_138" class="t s2_138">207. Marta, GN, et al.,</span><span id="t4_138" class="t m0_138 s3_138">Intensity-modulated radiation therapy for head and neck cancer: systematic review and </span>
<span id="t5_138" class="t m0_138 s3_138">meta-analysis.</span><span id="t6_138" class="t s2_138">Radiother Oncol, 2014.110(1): pp. 9-15. </span>
<span id="t7_138" class="t s2_138">208. Nuyts, S., et al.,</span><span id="t8_138" class="t m0_138 s3_138">Reduction of the dose to the elective neck in head and neck squamous cell </span>
<span id="t9_138" class="t m0_138 s3_138">carcinoma, a randomized clinical trial using intensity modulated radiotherapy (IMRT). Dosimetric </span>
<span id="ta_138" class="t m0_138 s3_138">analysis and effect on acute toxicity.</span><span id="tb_138" class="t s2_138">Radiother Oncol, 2013.109(2): pp. 323-9. </span>
<span id="tc_138" class="t s2_138">209. Peters, LJ, et al.,</span><span id="td_138" class="t m0_138 s3_138">Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first </span>
<span id="te_138" class="t m0_138 s3_138">report of a prospective randomized trial.</span><span id="tf_138" class="t s2_138">Int J Radiat Oncol Biol Phys, 1993.26(1): pp. 3-11. </span>
<span id="tg_138" class="t s2_138">210. Withers, HR, LJ Peters, and JM Taylor,</span><span id="th_138" class="t m0_138 s3_138">Dose-response relationship for radiation therapy of </span>
<span id="ti_138" class="t m0_138 s3_138">subclinical disease.</span><span id="tj_138" class="t s2_138">Int J Radiat Oncol Biol Phys, 1995.31(2): pp. 353-9. </span>
<span id="tk_138" class="t s2_138">211. Dische, S., et al.,</span><span id="tl_138" class="t m0_138 s3_138">A randomized multicentre trial of CHART versus conventional radiotherapy in head and neck </span>
<span id="tm_138" class="t m0_138 s3_138">cancer.</span><span id="tn_138" class="t s2_138">Radiother Oncol, 1997.44(2): pp. 123-36. </span>
<span id="to_138" class="t s2_138">212. Nguyen-Tan, PF, et al.,</span><span id="tp_138" class="t m0_138 s3_138">Randomized phase III trial to test accelerated versus standard fractionation in </span>
<span id="tq_138" class="t m0_138 s3_138">combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy </span>
<span id="tr_138" class="t m0_138 s3_138">Oncology Group 0129 trial: long-term report of efficacy and toxicity.</span><span id="ts_138" class="t s2_138">J Clin Oncol, 2014.32(34): pp. </span>
<span id="tt_138" class="t s2_138">3858-66. </span>
<span id="tu_138" class="t s2_138">213. Ghadjar, P., et al.,</span><span id="tv_138" class="t m0_138 s3_138">Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head </span>
<span id="tw_138" class="t m0_138 s3_138">and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94).</span><span id="tx_138" class="t s2_138">Int J Radiat Oncol </span>
<span id="ty_138" class="t s2_138">Biol Phys, 2012.82(2): pp. 524-31. </span>
<span id="tz_138" class="t s2_138">214. Bensadoun, RJ, et al.,</span><span id="t10_138" class="t m0_138 s3_138">French multicenter phase III randomized study testing concurrent twicea-day </span>
<span id="t11_138" class="t m0_138 s3_138">radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: </span>
<span id="t12_138" class="t m0_138 s3_138">Results at 2 years (FNCLCC-GORTEC).</span><span id="t13_138" class="t s2_138">Int J Radiat Oncol Biol Phys, 2006.64(4): pp. 983-94. </span>
<span id="t14_138" class="t s2_138">215. Blanchard, P., et al.,</span><span id="t15_138" class="t m0_138 s3_138">Mixed treatment comparison meta-analysis of altered fractionated radiotherapy and </span>
<span id="t16_138" class="t m0_138 s3_138">chemotherapy in head and neck cancer.</span><span id="t17_138" class="t s2_138">J Clin Epidemiol, 2011.64(9): pp. 985-92. </span>
<span id="t18_138" class="t s2_138">216. Dietz, A., et al.,</span><span id="t19_138" class="t m0_138 s3_138">Chronic laryngeal edema as a late reaction after chemoradiotherapy. </span>
<span id="t1a_138" class="t m0_138 s3_138">[Chronic laryngeal edema as a late reaction to radiochemotherapy].</span><span id="t1b_138" class="t s2_138">ENT, 1998.46(8): p. 731- 8. </span>
<span id="t1c_138" class="t s2_138">217. Mancuso, AA, et al.,</span><span id="t1d_138" class="t m0_138 s3_138">Preradiotherapy computed tomography as a predictor of local control in supraglottic </span>
<span id="t1e_138" class="t m0_138 s3_138">carcinoma.</span><span id="t1f_138" class="t s2_138">J Clin Oncol, 1999.17(2): pp. 631-7. </span>
<span id="t1g_138" class="t s2_138">218. Pfreundner, L., et al.,</span><span id="t1h_138" class="t m0_138 s3_138">Induction chemotherapy with paclitaxel and cisplatin and CT-based 3D radiotherapy </span>
<span id="t1i_138" class="t m0_138 s3_138">in patients with advanced laryngeal and hypopharyngeal carcinomas--a possibility for organ </span>
<span id="t1j_138" class="t m0_138 s3_138">preservation.</span><span id="t1k_138" class="t s2_138">Radiother Oncol, 2003.68(2): pp. 163-70. </span>
<span id="t1l_138" class="t s2_138">219. Gregoire, V., et al.,</span><span id="t1m_138" class="t m0_138 s3_138">Proposal for the delineation of the nodal CTV in the node-positive and the post- </span>
<span id="t1n_138" class="t m0_138 s3_138">operative neck.</span><span id="t1o_138" class="t s2_138">Radiother Oncol, 2006.79(1): pp. 15-20. </span>
<span id="t1p_138" class="t s2_138">220. Gregoire, V., et al.,</span><span id="t1q_138" class="t m0_138 s3_138">Delineation of the neck node levels for head and neck tumors: a 2013 update. </span>
<span id="t1r_138" class="t m0_138 s3_138">DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. </span><span id="t1s_138" class="t s2_138">Radiother </span>
<span id="t1t_138" class="t s2_138">Oncol, 2014.110(1): pp. 172-81. </span>
<span id="t1u_138" class="t s2_138">221. Brouwer, C.L., et al.,</span><span id="t1v_138" class="t m0_138 s3_138">CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, </span>
<span id="t1w_138" class="t m0_138 s3_138">GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines.</span><span id="t1x_138" class="t s2_138">Radiother Oncol, </span>
<span id="t1y_138" class="t s2_138">2015.117(1): pp. 83-90. </span>
<span id="t1z_138" class="t s2_138">222. Terrell, JE, SG Fisher, and GT Wolf,</span><span id="t20_138" class="t m0_138 s3_138">Long-term quality of life after treatment of laryngeal </span>
<span id="t21_138" class="t m0_138 s3_138">cancer. The Veterans Affairs Laryngeal Cancer Study Group.</span><span id="t22_138" class="t s2_138">Arch Otolaryngol Head Neck Surg, 1998.124( </span>
<span id="t23_138" class="t s2_138">9): pp. 964-71. </span>
<span id="t24_138" class="t s2_138">223. Lefebvre, JL, et al.,</span><span id="t25_138" class="t m0_138 s3_138">Larynx preservation in pyriform sinus cancer: preliminary results of a European </span>
<span id="t26_138" class="t m0_138 s3_138">Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer </span>
<span id="t27_138" class="t m0_138 s3_138">Cooperative Group.</span><span id="t28_138" class="t s2_138">J Natl Cancer Inst, 1996.88(13): p. 890-9. </span>
<span id="t29_138" class="t s2_138">224. Lefebvre, JL, et al.,</span><span id="t2a_138" class="t m0_138 s3_138">Laryngeal preservation with induction chemotherapy for hypopharyngeal </span>
<span id="t2b_138" class="t m0_138 s3_138">Squamous cell carcinoma: 10-year results of EORTC trial 24891.</span><span id="t2c_138" class="t s2_138">Ann Oncol, 2012.23(10): pp. 2708-14. </span>
<span id="t2d_138" class="t s2_138">225. Grover, S., et al.,</span><span id="t2e_138" class="t m0_138 s3_138">Total Laryngectomy Versus Larynx Preservation for T4a Larynx Cancer: </span>
<span id="t2f_138" class="t m0_138 s3_138">Patterns of Care and Survival Outcomes.</span><span id="t2g_138" class="t s2_138">Int J Radiat Oncol Biol Phys, 2015.92(3): pp. 594-601. </span>
<span id="t2h_138" class="t s2_138">226. Lefebvre, JL, KK Ang, and P. Larynx Preservation Consensus,</span><span id="t2i_138" class="t m0_138 s3_138">Larynx preservation clinical </span>
<span id="t2j_138" class="t m0_138 s3_138">trial design: key issues and recommendations--a consensus panel summary.</span><span id="t2k_138" class="t s2_138">Head Neck, 2009. 31(4): pp. </span>
<span id="t2l_138" class="t s2_138">429-41. </span>
<span id="t2m_138" class="t s2_138">227. Lefebvre, JL, KK Ang, and P. Larynx Preservation Consensus,</span><span id="t2n_138" class="t m0_138 s3_138">Larynx preservation clinical </span>
<span id="t2o_138" class="t m0_138 s3_138">trial design: key issues and recommendations-a consensus panel summary.</span><span id="t2p_138" class="t s2_138">Int J Radiat Oncol Biol </span>
<span id="t2q_138" class="t s2_138">Phys, 2009.73(5): pp. 1293-303. </span>
<span id="t2r_138" class="t s2_138">228. Pointreau, Y., et al.,</span><span id="t2s_138" class="t m0_138 s3_138">Randomized trial of induction chemotherapy with cisplatin and 5- </span>
<span id="t2t_138" class="t m0_138 s3_138">fluorouracil with or without docetaxel for larynx preservation.</span><span id="t2u_138" class="t s2_138">J Natl Cancer Inst, 2009.101(7): pp. </span>
<span id="t2v_138" class="t s2_138">498-506. </span>
<span id="t2w_138" class="t s0_138">© Oncology Guideline Program | S3 Guideline Laryngeal Carcinoma | Long Version 1.0 | January 2019 </span></div>
<!-- End text definitions -->


</div>
</body>
</html>
